123 related articles for article (PubMed ID: 9288321)
1. Squamous cell cancer cell lines: sensitivity to bleomycin and suitability for animal xenograft studies.
Jääskelä-Saari HA; Kairemo KJ; Ramsay HA; Grénman R
Acta Otolaryngol Suppl; 1997; 529():241-4. PubMed ID: 9288321
[TBL] [Abstract][Full Text] [Related]
2. Labelling of bleomycin with Auger-emitter increases cytotoxicity in squamous-cell cancer cell lines.
Jääskelä-Saari HA; Kairemo KJ; Ramsay HA; Grénman R
Int J Radiat Biol; 1998 May; 73(5):565-70. PubMed ID: 9652815
[TBL] [Abstract][Full Text] [Related]
3. Indium-111-bleomycin complex in squamous cell cancer xenograft tumors of nude mice.
Jääskelä-Saari HA; Grénman R; Ramsay HA; Tarkkanen J; Paavonen T; Kairemo KJ
Cancer Biother Radiopharm; 2005 Aug; 20(4):426-35. PubMed ID: 16114991
[TBL] [Abstract][Full Text] [Related]
4. Indium-111 bleomycin complex for radiochemotherapy of head and neck cancer--dosimetric and biokinetic aspects.
Kairemo KJ; Ramsay HA; Tagesson M; Jekunen AP; Paavonen TK; Jääskelä-Saari HA; Liewendahl K; Ljunggren K; Savolainen S; Strand SE
Eur J Nucl Med; 1996 Jun; 23(6):631-8. PubMed ID: 8662096
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of bleomycin and external radiation in squamous cell cancer cell lines of head and neck.
Jääskelä-Saari HA; Kairemo KJ; Jekunen AP; Pekkola-Heino K; Kulmala J; Ramsay HA; Grenman R
Cancer Detect Prev; 1996; 20(4):279-84. PubMed ID: 8818387
[TBL] [Abstract][Full Text] [Related]
6. Biokinetics of indium-111-bleomycin complex in head and neck cancer--implementations for radiochemotherapy.
Kairemo KJ; Ramsay HA; Paavonen TK; Jääskelä-Saari HA; Tagesson M; Ljunggren K; Strand SE
Cancer Detect Prev; 1997; 21(1):83-90. PubMed ID: 9043768
[TBL] [Abstract][Full Text] [Related]
7. Enhanced killing of human small cell lung cancer by hyperthermia and indium-111-bleomycin complex.
Hou DY; Maruyama Y
J Surg Oncol; 1990 May; 44(1):5-9. PubMed ID: 1692949
[TBL] [Abstract][Full Text] [Related]
8. A new 111In-bleomycin complex for combined radiotherapy and chemotherapy.
Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Farkas RJ; Miller EE; Larson SM
J Surg Oncol; 1985 Jun; 29(2):91-8. PubMed ID: 2417055
[TBL] [Abstract][Full Text] [Related]
9. A low pH 111In-bleomycin complex: a tracer for radiochemotherapy of head and neck cancer.
Kairemo KJ; Ramsay H; Nikula TK; Hopsu EV; Taavitsainen MJ; Bondestam S; Hiltunen JV
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):135-9. PubMed ID: 7543289
[TBL] [Abstract][Full Text] [Related]
10. Killing lung cancer cells at cell-cycle phase by a new indium-111-bleomycin complex.
Hou DY; Ordonez JV; Cross RJ; Ross DD; Maruyama Y
J Surg Oncol; 1989 Feb; 40(2):73-8. PubMed ID: 2464720
[TBL] [Abstract][Full Text] [Related]
11. Killing of human lung cancer cells using a new [111In]bleomycin complex [111In]BLMC.
Hou DY; Hamburger AW; Beach JL; Maruyama Y
Cancer Invest; 1989; 7(6):543-50. PubMed ID: 2483533
[TBL] [Abstract][Full Text] [Related]
12. Imaging and staging of head and neck cancer using a low pH In-111-bleomycin complex.
Kairemo KJ; Ramsay HA; Paavonen T; Bondestam S
Eur J Cancer B Oral Oncol; 1996 Sep; 32B(5):311-21. PubMed ID: 8944834
[TBL] [Abstract][Full Text] [Related]
13. [A transplantable model of human laryngeal squamous carcinoma in nude mice].
Ye J; Li X; Shi L
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(5):292-4. PubMed ID: 8762511
[TBL] [Abstract][Full Text] [Related]
14. Differentiation status of human squamous cell carcinoma xenografts does not appear to correlate with the repopulation capacity of clonogenic tumour cells during fractionated irradiation.
Hessel F; Krause M; Helm A; Petersen C; Grenman R; Thames HD; Baumann M
Int J Radiat Biol; 2004 Oct; 80(10):719-27. PubMed ID: 15799617
[TBL] [Abstract][Full Text] [Related]
15. Changes in the fraction of total hypoxia and hypoxia subtypes in human squamous cell carcinomas upon fractionated irradiation: evaluation using pattern recognition in microcirculatory supply units.
Maftei CA; Bayer C; Shi K; Astner ST; Vaupel P
Radiother Oncol; 2011 Oct; 101(1):209-16. PubMed ID: 21641070
[TBL] [Abstract][Full Text] [Related]
16. EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model.
Gustafsson H; Kale A; Dasu A; Lund A; Edqvist PH; Roberg K
Cell Biochem Biophys; 2017 Dec; 75(3-4):299-309. PubMed ID: 28756482
[TBL] [Abstract][Full Text] [Related]
17. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.
Huang SM; Harari PM
Clin Cancer Res; 2000 Jun; 6(6):2166-74. PubMed ID: 10873065
[TBL] [Abstract][Full Text] [Related]
18. Site-specific drug delivery by photochemical internalization enhances the antitumor effect of bleomycin.
Berg K; Dietze A; Kaalhus O; Høgset A
Clin Cancer Res; 2005 Dec; 11(23):8476-85. PubMed ID: 16322311
[TBL] [Abstract][Full Text] [Related]
19. Combining polyamine depletion with radiation therapy for rapidly dividing head and neck tumors: strategies for improved locoregional control.
Petereit DG; Harari PM; Contreras L; Pickart MA; Verma AK; Gerner EW; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):891-8. PubMed ID: 8138442
[TBL] [Abstract][Full Text] [Related]
20. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
